However, weight-loss drugs are included in a small group of drugs that can be excluded from coverage 1 (though the statutory exception refers to agents used for weight loss, obesity drugs is used to refer to this group of medications in this analysis)
A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds especially well to tirzepatide, a medication that mimics two naturally occurring hormones involved in appetite and blood sugar regulation, moving the field closer to precision medicine for obesity
They are most effective when used as part of a comprehensive plan that includes nutrition, physical activity and behavioral support. Benefits of Non-Injectable GLP-1 Medications When appropriately prescribed and monitored, non-injectable GLP-1 medications may offer several benefits for patients managing obesity and metabolic health
The primary approved uses of these medications remain metabolic, but the emerging data is opening new avenues for clinical research into psychiatric and addiction-related treatments
GLP-1 prescriptions are not included in your membership